TTM
$60.33B
YoY change
+49.1%
5Y CAGR
+23.4%
Peak year (2025)
$54.62B
Cumulative gross profit
$554.21B
Gross Profit history chart for Eli Lilly (LLY) from 1985 to 2025
Latest: $54.62B
Gross Profit growth chart for Eli Lilly (LLY) from 1985 to 2025
Latest: +49.1%
Gross Profit history table for Eli Lilly (LLY) from 1985 to 2025
| 2025 | $54.62B | +49.1% | +$17.99B | ||
| 2024 | $36.62B | +35.4% | +$9.58B | ||
| 2023 | $27.04B | +23.4% | +$5.13B | ||
| 2022 | $21.91B | +4.3% | +$906.00M | ||
| 2021 | $21.01B | +10.2% | +$1.95B | ||
| 2020 | $19.06B | +8.3% | +$1.46B | ||
| 2019 | $17.60B | +4.7% | +$786.70M | ||
| 2018 | $16.81B | +8.3% | +$1.29B | ||
| 2017 | $15.53B | +0.1% | +$14.10M | ||
| 2016 | $15.51B | +4.0% | +$590.50M | ||
| 2015 | $14.92B | +1.6% | +$238.40M | ||
| 2014 | $14.68B | -19.3% | −$3.52B | ||
| 2013 | $18.20B | +2.2% | +$398.10M | ||
| 2012 | $17.81B | -7.3% | −$1.41B | ||
| 2011 | $19.22B | +2.7% | +$508.80M | ||
| 2010 | $18.71B | +6.4% | +$1.12B | ||
| 2009 | $17.59B | +10.0% | +$1.59B | ||
| 2008 | $16.00B | +11.2% | +$1.61B | ||
| 2007 | $14.38B | +18.4% | +$2.24B | ||
| 2006 | $12.14B | +8.7% | +$973.40M | ||
| 2005 | $11.17B | +5.1% | +$537.10M | ||
| 2004 | $10.63B | +7.3% | +$726.60M | ||
| 2003 | $9.91B | +11.3% | +$1.01B | ||
| 2002 | $8.90B | -5.1% | −$481.30M | ||
| 2001 | $9.38B | +1.5% | +$140.00M | ||
| 2000 | $9.24B | +10.8% | +$897.70M | ||
| 1999 | $8.34B | +8.2% | +$632.50M | ||
| 1998 | $7.71B | +17.7% | +$1.16B | ||
| 1997 | $6.55B | +15.6% | +$881.80M | ||
| 1996 | $5.67B | +4.4% | +$237.90M | ||
| 1995 | $5.43B | +21.7% | +$967.70M | ||
| 1994 | $4.46B | -8.7% | −$427.60M | ||
| 1993 | $4.89B | +5.5% | +$253.30M | ||
| 1992 | $4.64B | +6.1% | +$267.40M | ||
| 1991 | $4.37B | +11.6% | +$455.20M | ||
| 1990 | $3.92B | +24.3% | +$766.70M | ||
| 1989 | $3.15B | +7.2% | +$212.20M | ||
| 1988 | $2.94B | +16.3% | +$411.60M | ||
| 1987 | $2.53B | -1.0% | −$26.60M | ||
| 1986 | $2.55B | +14.4% | +$320.50M | ||
| 1985 | $2.23B | — | — |
- 2025$54.62B+49.1%
- 2024$36.62B+35.4%
- 2023$27.04B+23.4%
- 2022$21.91B+4.3%
- 2021$21.01B+10.2%
- 2020$19.06B+8.3%
- 2019$17.60B+4.7%
- 2018$16.81B+8.3%
- 2017$15.53B+0.1%
- 2016$15.51B+4.0%
- 2015$14.92B+1.6%
- 2014$14.68B-19.3%
- 2013$18.20B+2.2%
- 2012$17.81B-7.3%
- 2011$19.22B+2.7%
- 2010$18.71B+6.4%
- 2009$17.59B+10.0%
- 2008$16.00B+11.2%
- 2007$14.38B+18.4%
- 2006$12.14B+8.7%
- 2005$11.17B+5.1%
- 2004$10.63B+7.3%
- 2003$9.91B+11.3%
- 2002$8.90B-5.1%
- 2001$9.38B+1.5%
- 2000$9.24B+10.8%
- 1999$8.34B+8.2%
- 1998$7.71B+17.7%
- 1997$6.55B+15.6%
- 1996$5.67B+4.4%
- 1995$5.43B+21.7%
- 1994$4.46B-8.7%
- 1993$4.89B+5.5%
- 1992$4.64B+6.1%
- 1991$4.37B+11.6%
- 1990$3.92B+24.3%
- 1989$3.15B+7.2%
- 1988$2.94B+16.3%
- 1987$2.53B-1.0%
- 1986$2.55B+14.4%
- 1985$2.23B—
Gross Profit values are taken from Eli Lilly's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Eli Lilly (LLY)
According to Eli Lilly's latest reported financial statements, the company's current gross profit (TTM) is $60.33B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Eli Lilly (LLY) gross profit totalled $54.62B – surged 49.1% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Eli Lilly gross profit compounded at +23.4% per year, sustaining 11 straight years of year-over-year growth.
Across the available history, gross profit reached its high of $54.62B in 2025 and its low of $2.23B in 1985.
Eli Lilly Gross Profit by Year
Eli Lilly Gross Profit 2025: $54.62B
Eli Lilly gross profit in 2025 was $54.62B, surged 49.1% from 2024. This figure represents the highest annual value in the available history.
Eli Lilly Gross Profit 2024: $36.62B
2024's gross profit for Eli Lilly came in at $36.62B, surged 35.4% from 2023.
Eli Lilly Gross Profit 2023: $27.04B
Eli Lilly posted gross profit of $27.04B in 2023, grew 23.4% from 2022.
Eli Lilly Gross Profit 2022: $21.91B
In 2022, Eli Lilly reported gross profit of $21.91B, edged up 4.3% from 2021.
Eli Lilly Gross Profit 2021: $21.01B
Eli Lilly gross profit in 2021 was $21.01B.
See more financial history for Eli Lilly (LLY).
Sector peers by Gross Profit
Healthcare peers of Eli Lilly (LLY), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B | |
| $16.78B |
- $82.92B
- $68.56B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
Eli Lilly (LLY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation